Medical Device News Magazine

Kasada to Develop a Dual Branded Hotel Within the Largest Retail Led Mixed Use Development in Côte d’Ivoire

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Kasada, the leading independent real estate private equity platform dedicated to hospitality in sub-Saharan Africa, announced today that it will build a new dual-branded hotel in Abidjan within the largest retail-led mixed-use development currently being developed by HCCP. The complex, scheduled to open in 2024, will seek to be certified EDGE, the World Bank’s green building certification program, and will boast over 150 hotel keys, a shopping center with over 60 stores, restaurants, a mini entertainment park, offices, a co-working space, and a clinic.

Olivier Granet, Kasada’s Managing Partner and CEO, said: “We are proud of bringing to Angré’s district its very first international branded hotels and developing a project that will not only benefit our clients but also the local community. Through this greenfield program in this unique location, we demonstrate once more the innovative dynamics of Kasada.”

For this greenfield project in West Africa, Kasada has chosen to work with an innovative investment and development company that has a proven institutional track record. HCCP has previously successfully developed Cosmos Yopougon, a Grade A shopping center opened in 2018 in Abidjan’s largest municipality, that has been the shopping center with the highest footfall in Côte d’Ivoire since 2019.

With a strong commitment to incorporating the highest ESG standards into their projects, Kasada will ensure that the construction of the greenfield hotels and their operations meet the strictest international environmental and social standards. This will include reduced water consumption as well as efficient energy and waste management.

David Damiba, Kasada’s Managing Partner and CIO, added: “We look forward to the execution of this new expansion in Abidjan, a city where we have committed significant capital to date which testifies to our strong belief in the country’s robust macroeconomic outlook. With this combo hotel, we are targeting the economy and extended stay segment to provide an attractive offer at the right price, in the heart of a high-density area.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”